IN2014CN03307A - - Google Patents
Info
- Publication number
- IN2014CN03307A IN2014CN03307A IN3307CHN2014A IN2014CN03307A IN 2014CN03307 A IN2014CN03307 A IN 2014CN03307A IN 3307CHN2014 A IN3307CHN2014 A IN 3307CHN2014A IN 2014CN03307 A IN2014CN03307 A IN 2014CN03307A
- Authority
- IN
- India
- Prior art keywords
- methylene
- formula
- carbolactones
- pregn
- endometriosis
- Prior art date
Links
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/007—3 membered carbocyclic rings in position 6-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/069464 WO2012059594A1 (en) | 2010-11-04 | 2011-11-04 | Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity |
| DE102012212838 | 2012-07-23 | ||
| PCT/EP2012/071700 WO2013064620A1 (de) | 2011-11-04 | 2012-11-02 | 18-METHYL-6,7-METHYLEN-3-OXO-17-PREGN-4-EN-21,17β-CARBOLACTONE, PHARMAZEUTISCHE PRÄPARATE ENTHALTEND DIE GENANNTEN VERBINDUNGEN UND DEREN ANWENDUNG BEI DER THERAPIE DER ENDOMETRIOSE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03307A true IN2014CN03307A (enExample) | 2015-07-03 |
Family
ID=48191408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3307CHN2014 IN2014CN03307A (enExample) | 2011-11-04 | 2012-11-02 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140288035A1 (enExample) |
| JP (1) | JP2014532685A (enExample) |
| KR (1) | KR20140088197A (enExample) |
| CN (1) | CN103957921A (enExample) |
| AR (1) | AR088622A1 (enExample) |
| AU (1) | AU2012331089A1 (enExample) |
| BR (1) | BR112014010590A2 (enExample) |
| CA (1) | CA2854215A1 (enExample) |
| EA (1) | EA201400537A1 (enExample) |
| HK (1) | HK1199712A1 (enExample) |
| IL (1) | IL232325A0 (enExample) |
| IN (1) | IN2014CN03307A (enExample) |
| MX (1) | MX2014005367A (enExample) |
| TW (1) | TW201322986A (enExample) |
| WO (1) | WO2013064620A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| RS62297B1 (sr) | 2011-11-23 | 2021-09-30 | Therapeuticsmd Inc | Prirodne kombinovane hormonske supstitucione formulacije i terapije |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 天然の併用ホルモン補充療法剤及び療法 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| CN117417303B (zh) * | 2023-10-19 | 2024-07-09 | 黑龙江中医药大学 | 一种用于治疗子宫内膜异位症的药物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1183500B (de) | 1962-10-12 | 1964-12-17 | Schering Ag | Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe |
| FR1529949A (fr) | 1966-05-19 | 1968-06-21 | American Home Prod | Composés stéroïdes tels que 10-méthylgon-4-en-3-ones et leurs dérivés |
| DE1921396C3 (de) | 1969-04-23 | 1978-04-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 17 a-Hydroperoxy-16 a, 18-dimethyl-20ketosteroide, Verfahren zur Herstellung derselben, sowie weitere entsprechende Zwischenprodukte |
| DE2922500A1 (de) | 1979-05-31 | 1980-12-04 | Schering Ag | 6 beta .7 beta |
| DE19633685C1 (de) * | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| ATE442147T1 (de) | 2000-01-18 | 2009-09-15 | Bayer Schering Pharma Ag | Pharmazeutische zubereitung enthaltend drospirenon |
| CL2004000574A1 (es) * | 2003-03-21 | 2005-02-11 | Pharmacia Corp Sa Organizada B | Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion. |
| DE102007011105A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
| WO2012059594A1 (en) * | 2010-11-04 | 2012-05-10 | Bayer Pharma Aktiengesellschaft | Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity |
-
2012
- 2012-11-02 KR KR1020147014686A patent/KR20140088197A/ko not_active Withdrawn
- 2012-11-02 TW TW101140872A patent/TW201322986A/zh unknown
- 2012-11-02 EA EA201400537A patent/EA201400537A1/ru unknown
- 2012-11-02 MX MX2014005367A patent/MX2014005367A/es not_active Application Discontinuation
- 2012-11-02 HK HK15100197.4A patent/HK1199712A1/xx unknown
- 2012-11-02 AU AU2012331089A patent/AU2012331089A1/en not_active Abandoned
- 2012-11-02 CN CN201280054180.0A patent/CN103957921A/zh active Pending
- 2012-11-02 WO PCT/EP2012/071700 patent/WO2013064620A1/de not_active Ceased
- 2012-11-02 AR ARP120104105A patent/AR088622A1/es unknown
- 2012-11-02 IN IN3307CHN2014 patent/IN2014CN03307A/en unknown
- 2012-11-02 CA CA2854215A patent/CA2854215A1/en not_active Abandoned
- 2012-11-02 JP JP2014539339A patent/JP2014532685A/ja active Pending
- 2012-11-02 BR BR112014010590A patent/BR112014010590A2/pt not_active Application Discontinuation
- 2012-11-02 US US14/356,165 patent/US20140288035A1/en not_active Abandoned
-
2014
- 2014-04-29 IL IL232325A patent/IL232325A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012331089A1 (en) | 2014-05-22 |
| IL232325A0 (en) | 2014-06-30 |
| TW201322986A (zh) | 2013-06-16 |
| CA2854215A1 (en) | 2013-05-10 |
| MX2014005367A (es) | 2014-07-09 |
| BR112014010590A2 (pt) | 2017-05-02 |
| CN103957921A (zh) | 2014-07-30 |
| HK1199712A1 (en) | 2015-07-17 |
| US20140288035A1 (en) | 2014-09-25 |
| EA201400537A1 (ru) | 2014-10-30 |
| AR088622A1 (es) | 2014-06-25 |
| KR20140088197A (ko) | 2014-07-09 |
| WO2013064620A1 (de) | 2013-05-10 |
| JP2014532685A (ja) | 2014-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03307A (enExample) | ||
| IN2014DN10670A (enExample) | ||
| PH12014502397B1 (en) | Pesticidal compositions and processes related thereto | |
| WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
| MX2016001037A (es) | Inhibidores de factores de transcripción y usos. | |
| IN2015DN01156A (enExample) | ||
| HK1216176A1 (zh) | 用於治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物 | |
| PL3378862T3 (pl) | Dihydropirymidynoizochinolinony i ich kompozycie farmaceutyczne do leczenia stwardnienia rozsianego | |
| IN2014MN02652A (enExample) | ||
| PH12013502686A1 (en) | Pesticidal compositions and processes related thereto | |
| BR112015000561A2 (pt) | inibidores de irak e usos dos mesmos | |
| MX2013004491A (es) | Boronatos como inhibidores de arginasa. | |
| EA019744B9 (ru) | Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами | |
| UA114656C2 (uk) | Похідні піридину | |
| PH12013500467A1 (en) | Pharmaceutical composition | |
| BR112013016862A2 (pt) | combinação de um agonista de opioide e um antagonista de opioide no tratamento de doença de parkinson | |
| MY183974A (en) | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| PL2739615T3 (pl) | Fenylo-3-aza-bicyklo[3.1.0]heks-3-ylo-metanony i ich zastosowanie jako leki | |
| MY162397A (en) | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation | |
| UA107550C2 (uk) | Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів | |
| WO2011150190A3 (en) | Hcv inhibitor compounds and methods of use thereof | |
| GB2497453B (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| SG10201900541QA (en) | Derivatives of xanthone compounds | |
| IN2014CN00572A (enExample) |